{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T15:21:29Z","timestamp":1776525689756,"version":"3.51.2"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.ejphar.2008.04.025","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T20:35:19Z","timestamp":1208464519000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Aspirin induces lytic cytotoxicity in Epstein\u2013Barr virus-positive cells"],"prefix":"10.1016","volume":"589","author":[{"given":"Su-Fang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Yun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Guang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2008.04.025_bib1","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.3816\/CLC.2005.s.006","article-title":"Targeting multiple signal transduction pathways in lung cancer","volume":"7","author":"Adjei","year":"2005","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.ejphar.2008.04.025_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/scbi.1996.0029","article-title":"Epstein\u2013Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma","volume":"7","author":"Ambinder","year":"1996","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbamcr.2006.01.005","article-title":"Aspirin-induced blockade of NF-kappaB activity restrains up-regulation of glial fibrillary acidic protein in human astroglial cells","volume":"1763","author":"Bae","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2008.04.025_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI11991","article-title":"Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB","volume":"107","author":"Baldwin","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2008.04.025_bib5","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1128\/JVI.77.15.8532-8540.2003","article-title":"NF-kappaB inhibits gammaherpesvirus lytic replication","volume":"77","author":"Brown","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1745-7270.2005.00032.x","article-title":"Induction of Epstein\u2013Barr virus lytic replication by recombinant adenoviruses expressing the zebra gene with EBV specific promoters","volume":"37","author":"Chen","year":"2005","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"key":"10.1016\/j.ejphar.2008.04.025_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2174\/156801105774574649","article-title":"Inhibition of PI3K\/Akt signaling: an emerging paradigm for targeted cancer therapy","volume":"5","author":"Chen","year":"2005","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.ejphar.2008.04.025_bib8","first-page":"7345","article-title":"A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo","volume":"63","author":"Christensen","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2008.04.025_bib9","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1073\/pnas.82.12.4085","article-title":"Activation of expression of latent Epstein\u2013Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA","volume":"82","author":"Countryman","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2008.04.025_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejphar.2005.05.024","article-title":"Aspirin inhibits NF-kappaB activation in a glycolysis-depleted lung epithelial cell line","volume":"517","author":"Cuesta","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib11","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1158\/0008-5472.CAN-06-1006","article-title":"Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression","volume":"66","author":"Feng","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2008.04.025_bib12","doi-asserted-by":"crossref","first-page":"10951","DOI":"10.1128\/JVI.76.21.10951-10959.2002","article-title":"Use of adenovirus vectors expressing Epstein\u2013Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors","volume":"76","author":"Feng","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib13","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1128\/JVI.75.10.4475-4481.2001","article-title":"Herpesvirus lytic replication and the cell cycle: arresting new developments","volume":"75","author":"Flemington","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-1-4615-0081-0_19","article-title":"Development of the epidermal growth factor receptor inhibitor Tarceva (OSI-774)","volume":"532","author":"Grunwald","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib15","first-page":"969","article-title":"Switching viral latency to viral lysis: a novel therapeutic approach for Epstein\u2013Barr virus-associated neoplasia","volume":"56","author":"Gutierrez","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2008.04.025_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0140-6736(90)90002-M","article-title":"Epstein\u2013Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma","volume":"335","author":"Harabuchi","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2008.04.025_bib17","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1128\/jvi.69.4.2168-2174.1995","article-title":"LMP-1 activates NF-kappa B by targeting the inhibitory molecule I kappa B alpha","volume":"69","author":"Herrero","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib18","first-page":"549","article-title":"The Epstein\u2013Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain","volume":"10","author":"Huen","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2008.04.025_bib19","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1038\/sj.onc.1206548","article-title":"Virally targeted therapies for EBV-associated malignancies","volume":"22","author":"Israel","year":"2003","journal-title":"Oncogene"},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2008.04.025_bib20","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1677\/erc.1.00992","article-title":"Clinical trials of intracellular signal transductions inhibitors for breast cancer\u2014a strategy to overcome endocrine resistance","volume":"12","author":"Johnston","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ejphar.2008.04.025_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc780","article-title":"NF-kappaB in cancer: from innocent bystander to major culprit","volume":"2","author":"Karin","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2008.04.025_bib22","doi-asserted-by":"crossref","first-page":"7654","DOI":"10.1128\/jvi.67.12.7654-7658.1993","article-title":"Epstein\u2013Barr virus induces fragmentation of chromosomal DNA during lytic infection","volume":"67","author":"Kawanishi","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib23","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2003-03-0930","article-title":"Direct killing of Epstein\u2013Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1","volume":"103","author":"Landais","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2008.04.025_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1056\/NEJM199501053320104","article-title":"The association of Epstein\u2013Barr virus with smooth-muscle tumors occurring after organ transplantation","volume":"332","author":"Lee","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2008.04.025_bib25","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1172\/JCI26322","article-title":"IKK\/NF-kappaB signaling: balancing life and death\u2014a new approach to cancer therapy","volume":"115","author":"Luo","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2008.04.025_bib26","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1128\/jvi.69.5.2968-2976.1995","article-title":"Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein\u2013Barr virus","volume":"69","author":"Mitchell","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1615\/JEnvironPatholToxicolOncol.v21.i2.130","article-title":"Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks","volume":"21","author":"Moran","year":"2002","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib28","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1096\/fj.00-0843fje","article-title":"Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage","volume":"15","author":"Muller","year":"2001","journal-title":"Faseb J."},{"key":"10.1016\/j.ejphar.2008.04.025_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/157016106775203126","article-title":"Angiotensin II regulates vascular and endothelial dysfunction: recent topics of angiotensin II type-1 receptor signaling in the vasculature","volume":"4","author":"Nakashima","year":"2006","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199509143331103","article-title":"Clonal proliferations of cells infected with Epstein\u2013Barr virus in preinvasive lesions related to nasopharyngeal carcinoma","volume":"333","author":"Pathmanathan","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2008.04.025_bib31","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1128\/JVI.77.8.5000-5007.2003","article-title":"Latent membrane protein 1 inhibits Epstein\u2013Barr virus lytic cycle induction and progress via different mechanisms","volume":"77","author":"Prince","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib32","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.1128\/JVI.72.10.7978-7984.1998","article-title":"The Epstein\u2013Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes","volume":"72","author":"Ragoczy","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib33","series-title":"Fields Virology","first-page":"2397","article-title":"Epstein\u2013Barr virus","author":"Rickinson","year":"1996"},{"key":"10.1016\/j.ejphar.2008.04.025_bib34","first-page":"769","article-title":"Epstein\u2013Barr virus-associated gastric adenocarcinoma","volume":"140","author":"Shibata","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib35","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1378\/chest.128.6.3975","article-title":"Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists","volume":"128","author":"Silvestri","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2008.04.025_bib36","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/003655200750023075","article-title":"Detection of Epstein\u2013Barr virus DNA in hepatocellular carcinoma tissues from hepatitis C-positive patients","volume":"35","author":"Sugawara","year":"2000","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues","volume":"94","author":"Thun","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejphar.2008.04.025_bib38","first-page":"67","article-title":"BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein\u2013Barr virus-positive tumor cells","volume":"24","author":"Wang","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejphar.2008.04.025_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2008.04.025_bib40","first-page":"718","article-title":"LMP1 activates NF-kappa B via degradation of I kappa B alpha in nasopharyngeal carcinoma cells","volume":"114","author":"Yin","year":"2001","journal-title":"Chin. Med. J. (Engl)."},{"key":"10.1016\/j.ejphar.2008.04.025_bib41","first-page":"273","article-title":"Epstein\u2013Barr virus, lymphomas and Hodgkin's disease","volume":"3","author":"Young","year":"1992","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejphar.2008.04.025_bib42","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein\u2013Barr virus: 40\u00a0years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2008.04.025_bib43","first-page":"132","article-title":"Epstein\u2013Barr virus infection of sinonasal lymphoepithelial carcinoma in Guangzhou","volume":"114","author":"Zong","year":"2001","journal-title":"Chin. Med. J. (Engl)."},{"key":"10.1016\/j.ejphar.2008.04.025_bib44","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/272373a0","article-title":"Persisting oncogenic herpesvirus induced by the tumour promotor TPA","volume":"272","author":"Zur Hausen","year":"1978","journal-title":"Nature"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908003907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908003907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T20:01:18Z","timestamp":1728417678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908003907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":44,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0014299908003907"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.04.025","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin induces lytic cytotoxicity in Epstein\u2013Barr virus-positive cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}